-+ 0.00%
-+ 0.00%
-+ 0.00%

VERU ENROLLS FIRST PATIENT IN PHASE 2B PLATEAU CLINICAL TRIAL OF ENOBOSARM AND SEMAGLUTIDE COMBINATION FOR HIGH QUALITY WEIGHT LOSS

Reuters·03/09/2026 12:30:00

Please log in to view news